national pharmaceutical network, inc.

4300 new getwell rd
memphis, tennessee 38118

NYS Entity Status
ACTIVE

NYS Filing Date
NOVEMBER 14, 2013

NYS DOS ID#
4487364

County
JEFFERSON

Jurisdiction
FLORIDA

Registered Agent
NONE

NYS Entity Type
FOREIGN BUSINESS CORPORATION

Name History
2013 - NATIONAL PHARMACEUTICAL NETWORK, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Alexandria Debuts NY’s Latest Bio Incubator With 13 Startups in Tow
    By Ben Fidler - Tuesday Jun 13, 2017

    A new startup incubator has just opened in Manhattan this morning, adding to a growing list of facilities meant to help support seedling New York City biotechs. LaunchLabs, first announced by Alexandria Real Estate Equities a year ago, officially opened its doors and revealed the 13 startups that will grow there. LaunchLabs is a 15,000-square-foot […]

    Source: Xconomy New York
  • Alexandria Debuts NY’s Latest Bio Incubator With 13 Startups in Tow
    By Ben Fidler - Tuesday Jun 13, 2017

    A new startup incubator has just opened in Manhattan this morning, adding to a growing list of facilities meant to help support seedling New York City biotechs. LaunchLabs, first announced by Alexandria Real Estate Equities a year ago, officially opened its doors and revealed the 13 startups that will grow there. LaunchLabs is a 15,000-square-foot […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Martin Shkreli, ‘Pharma Bro,’ Prepares for Trial: ‘I’m So Innocent’
    By STEPHANIE CLIFFORD - Thursday Jun 22, 2017

    The former hedge fund manager, vilified by the public and politicians after increasing the price of a prescription drug, is facing eight counts of securities and wire fraud.

    Source: NYT > Home Page
  • Checkmate Pharma Clinches $27M for More Studies in Skin Cancer
    By Frank Vinluan - Thursday Jun 15, 2017

    Checkmate Pharmaceuticals believes its approach to cancer treatment can make a certain type of immunotherapy work better, and it now has $27 million in additional funding to help build that case. F-Prime Capital Partners, a new investor, led the Series B round of investment announced Thursday. Sofinnova Partners and venBio, who had invested in Cambridge, […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Insurers Battle Families Over Costly Drug for Fatal Disease
    By KATIE THOMAS - Thursday Jun 22, 2017

    The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.

    Source: NYT > Home Page
  • Europe cyberattack also breaches Merck headquarters in US
    By Linda Massarella - Tuesday Jun 27, 2017

    Pharmaceutical giant Merck — whose US headquarters is in Kenilworth, NJ — confirmed Tuesday its computer network was hacked as part of a new, massive cyberattack in Europe. “We confirm our company’s computer network was compromised today as part of global hack,”

    Source: New York Post: News
  • Expanding Teladoc Adds Network, Tech With $440M Best Doctors Deal
    By David Holley - Tuesday Jun 20, 2017

    Dallas—In Teladoc’s acquisition of Boston-based Best Doctors—a $440 million cash-and-stock deal that the companies announced Monday—Teladoc (NYSE: TDOC) is gaining a business that lets it offer more specialization in its telemedicine services. Best Doctors connects individuals who have tough decisions to make about treatments—or who want a second opinion about a diagnosis—with top-rated doctors worldwide. […]

    Source: Xconomy New York
  • Expanding Teladoc Adds Network, Tech With $440M Best Doctors Deal
    By David Holley - Monday Jun 19, 2017

    Dallas—In Teladoc’s acquisition of Boston-based Best Doctors—a $440 million cash-and-stock deal that the companies announced Monday—Teladoc (NYSE: TDOC) is gaining a business that lets it offer more specialization in its telemedicine services. Best Doctors connects individuals who have tough decisions to make about treatments—or who want a second opinion about a diagnosis—with top-rated doctors worldwide. […]

    Source: Xconomy VC, Deals, & Startups Feed